Back

Combining polygenic risk score and high platelet reactivity for incremental predictive value of acute myocardial infarction in patients with coronary artery disease with 10-year follow-up

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Predicting the continuum of cardiovascular disease Scores ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Xueyan Zhao

Fuwai Hospital, CAMS and PUMC, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Hemodynamic response to exercise and cardiovascular risk in patients with normal myocardial perfusion
Doctor J. Lu (Boston, US)
Abstract Slides
Presentation thumbnail
Normal coronary computed tomography angiography and long-term cardiovascular risk: implications for SCORE2–guided primary prevention
Doctor K. Olesen (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Inflammatory and insulin resistance indicators for predicting in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention
Mr J. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Predominant contribution of lifestyle versus metabolic risk factors to early-onset myocardial infarction (EOMI)
Doctor Y. Zhu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Functional capacity and cardiovascular risk burden: a cross-sectional analysis of the six-minute walk test in an at-risk population from 47 primary health centers in Indonesia
Associate Professor A. Qanitha (Makassar, ID)
Abstract Slides

Access the full session

Session thumbnail
Predicting the continuum of cardiovascular disease

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Association between genetic polymorphisms in multiple thrombosis-related genes and long-term prognosis in coronary artery disease patients: a large-scale cohort study
1 September 2025
thumbnail
Webinar
Polygenic risk scores: what is their value for risk prediction and potential for clinical utility?
22 March 2022
thumbnail
Congress Presentation
Predicting individualized treatment effects of prasugrel vs ticagrelor for acute coronary syndrome: a post hoc analysis of a randomized clinical trial
31 August 2025
thumbnail
Congress Presentation
Clinical risk score for prediction of early left ventricular thrombus after percutaneous coronary intervention for ST-elevation myocardial infarction
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources